A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

August 31, 2013

Study Completion Date

May 31, 2014

Conditions

HBeAg(+) Chronic Hepatitis B

Interventions

DRUG

Clevudine

30mg,QD

DRUG

Clevudine + Peg-interferon

30mg, QD(for 24 weeks) + 180mcg,QW(for 24 weeks)

Trial Locations (1)

Uijeongbu St.Mary's Hospital, Uijeongbu-si